AlzChem Group AG Stock
AlzChem Group AG Stock
AlzChem Group AG dominated the market today, gaining €6.20 (3.800%).
For the coming years our community has positive and negative things to say abot the AlzChem Group AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of AlzChem Group AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AlzChem Group AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AlzChem Group AG | 3.800% | 9.032% | 16.552% | 64.878% | 9.598% | 798.936% | 584.211% |
| SNP Schneider-Neureither & Partner AG | 0.490% | 1.724% | 0.487% | 21.829% | 7.833% | 180.475% | 61.961% |
| adesso SE | -0.960% | -6.354% | -3.130% | -28.604% | -30.449% | -57.369% | -44.234% |
| NorCom Information Technology GmbH & Co. KGAA | 2.550% | -3.521% | 0.000% | -62.973% | -13.836% | -80.812% | -84.912% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18
Looking at the financials of AlzChem, a company in the Software & IT Services industry, one can observe a positive trend in the company's growth. Net income and total assets have gradually increased over the past three years, which is generally a positive sign. However, a closer examination of various financial aspects is necessary for a comprehensive analysis.
*Pros: *
Growth in total assets: The total assets for AlzChem have experienced consistent growth over the last three years, from €354.3 million in 2020 to €422.8 million in 2022. This growth reflects an improvement in the company's overall financial health.
Comments
systinvest hat das Wertpapier AlzChem Group AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more
News
EQS-News: Alzchem Group AG achieves record year in 2025: once again, record figures for sales and EBITDA thanks to proven focus on specialty chemicals and ingredients
EQS-News: Alzchem Group AG achieves record year in 2025: once again, record figures for sales and EBITDA thanks to proven focus on specialty chemicals and ingredients
EQS-News: Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
EQS-News: Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule